IP Library › Patent Application 61682315
Patent Application Provisional Small
App. No. 61/682,315 · Confirmation No. 7985

Use of Amitifadine, (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane, in Methods and Compositions With Enhanced Efficacy and Reduced Metabolic Side Effects and Toxicity for Treatment of Depression and Other Central Nervous System Disorders and Conditions Affected by Monoamine Neurotransmitters

Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2012-11-13 APP.FILE.REC Filing Receipt 3 View
2012-10-31 PEFR Applicant Response to Pre-Exam Formalities Notice 3 View
2012-08-23 NTC.MISS.PRT Notice to File Missing Parts 1 View
2012-08-23 APP.FILE.REC Filing Receipt 3 View
2012-08-13 TR.PROV Provisional Cover Sheet (SB16) 2 View
2012-08-13 SPEC Specification 171 View
2012-08-13 CLM Claims 18 View
2012-08-13 ABST Abstract 1 View
2012-08-13 DRW Drawings-only black and white line drawings 17 View
2012-08-13 WFEE Fee Worksheet (SB06) 2 View
2012-08-13 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
61/682,315
Filed
2012-08-13